Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer-oriented API manufacturer. We have a legacy of over three decades and trace our origins to the API expertise of Strides Shasun Ltd. and the technical knowhow of human API business from Sequent Scientific Ltd. We are poised to bridge the industry gap by delivering value-based products while maintaining focus on customer needs. We have 140+ scientists working at our two R&D Centers and 4 API manufacturing facilities armed with global approvals and 2 dedicated R&D facilities.

 

Top

Stock Exchange Communication

Solara / Investor Relations / Stock Exchange Communication
  • Outcome of Second Annual General Meeting
  • Press Release - USFDA Inspection Cuddalore Facility
  • Outcome of Board Meeting
  • Intimation of Analysts Institutional Investors Conference Call
  • Board Meeting Imitation
  • Closure of Trading Window
  • Financial Results - FY 18-19
  • EGM Notice and Information on e-Voting
  • Outcome of Board Meeting - Issue of Convertible Warrants
  • Intimation of Board Meeting for Capital raising - Securities
  • Press release – Ambernath facility completes USFDA Inspection
  • Change in CIN of the Company
  • Press release - SRC completes USFDA Inspection
  • Employee Stock Option Plans
  • Change in Board
  • Acquisition of Strides Chemicals Pvt. Ltd
  • Press Release - Updates on Ranitidine Hydrochloride & Nizatidine API
  • Newspaper Advertisement
Proceedings of the Second AGM

DOWNLOAD
Voting Results of the Second AGM

DOWNLOAD
Intimation of Board Meeting

DOWNLOAD
Intimation of Analysts / Institutional Investors Conference Call

DOWNLOAD
Press release - Solara's Cuddalore facility completes USFDA Inspection

DOWNLOAD
Appointment of Director

DOWNLOAD
Grant of ESOP options

DOWNLOAD
Dividend for the Financial Year 31st March 2019

DOWNLOAD
Intimation of Analysts Institutional Investors Conference Call

DOWNLOAD
Intimation of Board Meeting

DOWNLOAD
Board Meeting Intimation August 2018

DOWNLOAD
Closure of Trading Window

DOWNLOAD
Q3 Financial Results

DOWNLOAD
EGM Notice and Information on e-Voting

DOWNLOAD
Voting Results of the EGM

DOWNLOAD
Outcome of Board Meeting - Issue of Convertible Warrants

DOWNLOAD
Intimation of Board Meeting for Capital raising through Issuance of Securities

DOWNLOAD
Press release – Ambernath facility completes USFDA Inspection with Zero 483s

DOWNLOAD
Change in CIN of the Company

DOWNLOAD
Press release - SRC completes USFDA Inspection

DOWNLOAD
Employee Stock Option Plans

DOWNLOAD
Change in Board

DOWNLOAD
Newspaper Advertisement

DOWNLOAD
Equity Shareholders Meeting Notice

DOWNLOAD
Unsecured Creditors Meeting Notice

DOWNLOAD
Update on Investment in Strides Chemicals Private Limited

DOWNLOAD
Merger Scheme and Board Resolution

DOWNLOAD
Press Release - Updates on Ranitidine Hydrochloride & Nizatidine API

DOWNLOAD
Business Standard, June 2018 - Page 1

DOWNLOAD
Business Standard, June 2018 - Page 2

DOWNLOAD
Business Standard, June 2018 - Page 3

DOWNLOAD